USA - NYSE:BBLN - JE00BQWMWC12 - Common Stock
The current stock price of BBLN is 0.5504 USD. In the past month the price decreased by -17.84%. In the past year, price decreased by -97.82%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 39.09 | 47.73B | ||
| DOCS | DOXIMITY INC-CLASS A | 44.3 | 12.36B | ||
| WAY | WAYSTAR HOLDING CORP | 26.75 | 6.84B | ||
| HTFL | HEARTFLOW INC | N/A | 3.10B | ||
| CERT | CERTARA INC | 23.73 | 1.87B | ||
| SDGR | SCHRODINGER INC | N/A | 1.55B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.52B | ||
| PHR | PHREESIA INC | N/A | 1.36B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 9.63 | 1.17B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.08B | ||
| CTEV | CLARITEV CORP | N/A | 1.07B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | N/A | 891.51M |
Babylon Holdings Ltd. engages in the development of a mobile phone-based healthcare application. The company is headquartered in Austin, Texas and currently employs 1,895 full-time employees. The company went IPO on 2021-03-30. The firm's digital clinical platform makes information available to members so that they can monitor their health information on mobile devices, delivering digital care in countries as varied as the United States and Rwanda. The company provides 24/7 digital access to medical professionals in the United States and the United Kingdom. Its platform delivers standardized treatment protocols, administrative practices, technology, and automation, such as care for acute and chronic conditions, including chronic pain, pregnancy, cardiovascular disease, diabetes, and numerous other health concerns in a longitudinal manner. Its flagship holistic solution, Babylon 360, combines its cutting-edge technologies with human clinical expertise and provides managed care for its members across the care continuum.
BABYLON HOLDINGS LTD- CL A
2500 Bee Cave Road, Building 1 - Suite 400
Austin TEXAS US
Employees: 1895
Phone: 442071000762.0
Babylon Holdings Ltd. engages in the development of a mobile phone-based healthcare application. The company is headquartered in Austin, Texas and currently employs 1,895 full-time employees. The company went IPO on 2021-03-30. The firm's digital clinical platform makes information available to members so that they can monitor their health information on mobile devices, delivering digital care in countries as varied as the United States and Rwanda. The company provides 24/7 digital access to medical professionals in the United States and the United Kingdom. Its platform delivers standardized treatment protocols, administrative practices, technology, and automation, such as care for acute and chronic conditions, including chronic pain, pregnancy, cardiovascular disease, diabetes, and numerous other health concerns in a longitudinal manner. Its flagship holistic solution, Babylon 360, combines its cutting-edge technologies with human clinical expertise and provides managed care for its members across the care continuum.
The current stock price of BBLN is 0.5504 USD. The price decreased by -13.99% in the last trading session.
BBLN does not pay a dividend.
BBLN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
BABYLON HOLDINGS LTD- CL A (BBLN) operates in the Health Care sector and the Health Care Technology industry.
BABYLON HOLDINGS LTD- CL A (BBLN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-18.28).
You can find the ownership structure of BABYLON HOLDINGS LTD- CL A (BBLN) on the Ownership tab.
ChartMill assigns a fundamental rating of 2 / 10 to BBLN. BBLN has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months BBLN reported a non-GAAP Earnings per Share(EPS) of -18.28. The EPS decreased by -112.81% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
7 analysts have analysed BBLN and the average price target is 7.65 USD. This implies a price increase of 1289.9% is expected in the next year compared to the current price of 0.5504.
For the next year, analysts expect an EPS growth of 57.13% and a revenue growth 11.12% for BBLN